(Q55060170)

16 June 2018

title

Effects of a ketamine metabolite on synaptic NMDAR function. (English)

1 reference

16 June 2018

4

Ege T Kavalali

1 reference

16 June 2018

5

Lisa M Monteggia

1 reference

16 June 2018

Kanzo Suzuki

1

1 reference

16 June 2018

Elena Nosyreva

series ordinal

2

1 reference

16 June 2018

Kevin W Hunt

series ordinal

3

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 June 2017

1 reference

16 June 2018

published in

Nature

1 reference

16 June 2018

volume

546

1 reference

16 June 2018

issue

7659

1 reference

16 June 2018

page(s)

E1-E3

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1038/nature22084

exact match

0 references

cites work

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Acute suppression of spontaneous neurotransmission drives synaptic potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Memantine binding to a superficial site on NMDA receptors contributes to partial trapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

Antidepressant Actions of Ketamine Versus Hydroxynorketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE22084

inferred from DOI database lookup

7 January 2021

based on heuristic

The route of absorption of intraperitoneally administered compounds

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28640258

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NATURE22084

1 reference

16 June 2018

Dimensions Publication ID

1086108749

0 references

1 reference

16 June 2018